Silchar Medical College and Hospital, Silchar.
J Assoc Physicians India. 2022 Apr;70(4):11-12.
Since December 2019, an emerging coronavirus called Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) has been spreading worldwide. Older people and those with comorbidities are more likely to develop severe illness. Vaccines against coronavirus have been developed recently. In India, the two vaccine currently authorized to use are namely ChAdOx1 nCov, Covishield and Covaxin; both of which require 2 shots few weeks apart for adequate protection. Although COVID antibody test has not been done following vaccination in my subjects, it was observed that those who were vaccinated with one or two doses had less clinical severity compared to non vaccinated patients. In this study, we did a comparative analysis of the laboratory markers of severity in elderly COVID patients who were fully vaccinated, partially vaccinated and non vaccinatednon-vaccinated.
This study is conducted with COVID-19 patients in age group more than 65 years for duration of 6 months. Participants were divided in three group Fully Vaccinated group who received 2 doses, Partially Vaccinated group with only 1 dose and non-vaccinated group. Assessment of inflammatory markers like CRP, LDH and Ferritin, Procalcitonin, RDW and NLR were done in the three groups.
A total of 52 fully vaccinated, 120 partially vaccinated and 458 non vaccinated patients were included in this study. The mean LDH, ferritin, procalcitonin, RDW, NLR in the fully vaccinated group were 381.61±167.53 U/l, 286.77±226.73 ng/ml, 0.40±0.32 ng/ml, 14.23±1.80 % and 8.85±10.36 respectively; that in the partially vaccinated group were 413.89±209.75 U/l, 387.44±317.55 ng/ml, 1.08±2.98 ng/ml, 14.45±1.42 % and 10.20±12.30 respectively; and in the non vaccinated group were 583.97±638.90 U/l, 479.03±332.85 ng/ml, 5.30±15.91 ng/ ml, 14.93±1.96 % and 11.97±12.57 respectively. Significant differences were found in terms of LDH, Ferritin, RDW and CRP among the groups with p values of <0.01, <0.0001, <0.01 and <0.05 respectively. However, no significant difference (p>0.05) was observed in terms of procalcitonin and NLR among the groups although the average values were found to increase from fully vaccinated to partially vaccinated to non-vaccinated groups.
Vaccination was associated with less severity when analysed in terms of laborotary parameters in COVID-19 elderly patients.
本研究旨在比较分析完全接种、部分接种和未接种疫苗的老年 COVID 患者的实验室严重程度指标。
这项研究纳入了年龄在 65 岁以上的 COVID-19 患者,持续时间为 6 个月。参与者被分为三组:完全接种组(接受 2 剂)、部分接种组(仅接种 1 剂)和未接种组。在三组中评估了 CRP、LDH 和铁蛋白、降钙素原、RDW 和 NLR 等炎症标志物。
共有 52 名完全接种、120 名部分接种和 458 名未接种患者纳入本研究。完全接种组的平均 LDH、铁蛋白、降钙素原、RDW、NLR 分别为 381.61±167.53 U/l、286.77±226.73 ng/ml、0.40±0.32 ng/ml、14.23±1.80%和 8.85±10.36%;部分接种组分别为 413.89±209.75 U/l、387.44±317.55 ng/ml、1.08±2.98 ng/ml、14.45±1.42%和 10.20±12.30%;未接种组分别为 583.97±638.90 U/l、479.03±332.85 ng/ml、5.30±15.91 ng/ml、14.93±1.96%和 11.97±12.57%。在 LDH、铁蛋白、RDW 和 CRP 方面,三组之间存在显著差异(p 值均小于 0.01)。然而,在降钙素原和 NLR 方面,三组之间没有观察到显著差异(p 值均大于 0.05),尽管平均数值显示从完全接种组到部分接种组再到未接种组逐渐升高。
在 COVID-19 老年患者中,从实验室参数方面分析,接种疫苗与病情严重程度较低相关。